SCHEMBL4364470

SCHEMBL4364470

c1ccc2c(c1)nnn2Oc1ncnc2sccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.60
ALDH1A1 P00352 4/20 0.60
LMNA P02545 2/20 0.60
SMN1; SMN2 Q16637 3/20 0.47
MRGPRX1 Q96LB2 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTT P42858 3/20 0.41
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
KMT2A Q03164 3/20 0.39
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
CHEK1 O14757 1/20 0.38
AURKA O14965 1/20 0.38
DAPK3 O43293 1/20 0.38
JAK2 O60674 1/20 0.38
MAP4K4 O95819 1/20 0.38
ABL1 P00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975732 0.82 ALDH1A1 (0.46) RAB9AALDH1A1LMNASMN1; SMN2MRGPRX1
SCHEMBL3978075 0.81 TSHR (0.45) RAB9AALDH1A1LMNACYP1A2CYP2C19
SCHEMBL15363851 0.72 BRD4 (0.47) RAB9AALDH1A1LMNASMN1; SMN2CYP1A2
SCHEMBL3983251 0.70 TSHR (0.49) RAB9AALDH1A1SMN1; SMN2CYP1A2TSHR
SCHEMBL3977843 0.69 HSD17B10 (0.48) RAB9AALDH1A1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL13265430 0.68 ADORA2A (0.39) RAB9ASMN1; SMN2TSHRNPSR1RXFP1
SCHEMBL28784934 0.68 MAP4K4 (0.38) RAB9AALDH1A1SMN1; SMN2CYP1A2TSHR
SCHEMBL29757284 0.68 MAP4K4 (0.38) RAB9AALDH1A1SMN1; SMN2CYP1A2TSHR
SCHEMBL3977779 0.67 ALDH1A1 (0.72) RAB9AALDH1A1LMNASMN1; SMN2MRGPRX1
SCHEMBL24121779 0.67 TSHR (0.37) RAB9AALDH1A1SMN1; SMN2HTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023113930-A2 FLEXIBLE OFDM WAVEFORM FOR JOINT COMMUNICATION AND RF SENSING QUALCOMM INCORPORATED (US) 2023-06-22 WO disclosed
US-10338944-B2 Automatic discovery and classfication of java virtual machines running on a logical partition of a computer INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2019-07-02 US disclosed
US-10235193-B2 Collecting performance metrics from Java virtual machines INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2019-03-19 US disclosed
US-20180060110-A1 COLLECTING PERFORMANCE METRICS FROM JAVA VIRTUAL MACHINES INTERNATIONAL BUSINESS MACHINES CORPORATION 2018-03-01 US disclosed
US-9836320-B2 Collecting performance metrics from java virtual machines INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2017-12-05 US disclosed
US-20170262305-A1 AUTOMATIC DISCOVERY AND CLASSFICATION OF JAVA VIRTUAL MACHINES RUNNING ON A LOGICAL PARTITION OF A COMPUTER INTERNATIONAL BUSINESS MACHINES CORPORATION 2017-09-14 US disclosed
US-20170262304-A1 COLLECTING PERFORMANCE METRICS FROM JAVA VIRTUAL MACHINES INTERNATIONAL BUSINESS MACHINES CORPORATION 2017-09-14 US disclosed
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION WYETH (US) 2009-11-26 US disclosed
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION WYETH (US) 2009-11-26 US disclosed
US-20090291310-A1 OPAL LATEX SUN CHEMICAL CORPORATION 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291971-A1 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AHR, MALT1, ABL1 RAB9A 3568/4885ALDH1A1 1591/4885LMNA 1994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.